Sudden cardiac death: the lost fatty acid hypothesis.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  QJM : monthly journal of the Association of Physicians

• Publication date

  2006-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/QJMED/HCL084PMID 16935924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis.

  2009cited by this paper
• Metabolic aspects of rhythm disturbances.

  2009cited by this paper
• The effect of antilipolytic agents on cyclic AMP, free fatty acid and total catecholamine concentrations in plasma.

  2009cited by this paper
• Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATEECLA Randomized Controlled Trial

  2006cited by this paper
• Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

  2005cited by this paper
• Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

  2005cited by this paper
• Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.

  2005cited by this paper
• Efficacy and Safety of a Metabolic Modulator Drug in Chronic Stable Angina: Review of Evidence from Clinical Trials

  2004cited by this paper
• Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy.

  2004cited by this paper
• Control of Heart Rate Versus Rhythm in Rheumatic Atrial Fibrillation: A Randomized Study

  2004cited by this paper
• Uncoupling proteins in human heart.

  2004cited by this paper
• Cardiac arrhythmias: the quest for a cure: a historical perspective.

  2004cited by this paper
• The nicotinic acid receptor--a new mechanism for an old drug.

  2004cited by this paper
• Free fatty acid metabolism during myocardial ischemia and reperfusion

  2004cited by this paper
• Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent

  2004cited by this paper
• Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.

  2003cited by this paper
• Lack of benefit of dietary advice to men with angina: results of a controlled trial

  2003cited by this paper
• Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial.

  2003cited by this paper
• N-[3-(R)-Tetrahydrofuranyl]-6-aminopurine Riboside, an A1 Adenosine Receptor Agonist, Antagonizes Catecholamine-Induced Lipolysis without Cardiovascular Effects in Awake Rats

  2003cited by this paper
• Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside.

  2003cited by this paper
• Metabolic modulation: a means to mend a broken heart.

  2002cited by this paper
• Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

  2002cited by this paper
• Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes.

  2002cited by this paper
• Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β‐cell dysfunction

  2002cited by this paper
• [Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations].

  2002cited by this paper
• Metabolic Approaches to the Treatment of Ischemic Heart Disease: The Clinicians' Perspective

  2002cited by this paper
• Blood levels of long-chain n-3 fatty acids and the risk of sudden death.

  2002cited by this paper
• Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.

  2002cited by this paper
• Task Force on Sudden Cardiac Death of the European Society of Cardiology.

  2001cited by this paper
• Circulating Nonesterified Fatty Acid Level as a Predictive Risk Factor for Sudden Death in the Population

  2001cited by this paper
• Characterization of a G protein-coupled receptor for nicotinic acid.

  2001cited by this paper
• Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?

  2000cited by this paper
• Myocardial Viability: A Clinical and Scientific Treatise

  2000cited by this paper
• Metabolism--the lost child of cardiology.

  2000cited by this paper
• Prevention of Sudden Cardiac Death by Dietary Pure ω-3 Polyunsaturated Fatty Acids in Dogs

  1999cited by this paper
• Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs.

  1999cited by this paper
• Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study.

  1999cited by this paper
• Metabolic approaches in ischaemic heart disease

  1999cited by this paper
• Optimizing cardiac energy metabolism : a new approach to treating ischaemic heart disease

  1999cited by this paper
• Cardiac fatty acid metabolism and the induction of apoptosis.

  1999cited by this paper
• Glucose-Insulin-Potassium (GIK) for Acute Myocardial Infarction: A Negative Study with a Positive Value

  1999cited by this paper
• Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction Final Report of the Lyon Diet Heart Study

  1999cited by this paper
• Metabolic derangement in ischemic heart disease and its therapeutic control.

  1998cited by this paper
• Why cholesterol as a central theme in coronary artery disease?

  1998cited by this paper
• Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism.

  1998cited by this paper
• Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial

  1998cited by this paper
• Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.

  1998cited by this paper
• Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions.

  1997cited by this paper
• Differential effects of various eicosanoids on the production or prevention of arrhythmias in cultured neonatal rat cardiac myocytes.

  1997cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Effects of Ranolazine on Ischemic Threshold, Coronary Sinus Blood Flow, and Myocardial Metabolism in Coronary Artery Disease

  1997cited by this paper
• Prevention of ischemia-induced cardiac Sudden death by n−3 polyunsaturated fatty acids in dogs

  1997cited by this paper
• Beta-blockers and sudden cardiac death.

  1995cited by this paper
• Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction.

  1995cited by this paper
• -Blockers and Sudden Cardiac Death

  1995cited by this paper
• Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.

  1994cited by this paper
• Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias.

  1994cited by this paper
• Electropharmacological control of cardiac arrhythmias : to delay conduction or to prolong refractoriness?

  1994cited by this paper
• Echocardiographic Study of the Morphology and Growth of the Aortic Arch in the Human Fetus: Observations Related to the Prenatal Diagnosis of Coarctation

  1992cited by this paper
• Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey.

  1992cited by this paper
• Effect of palmitic acid and fatty acid binding protein on ventricular fibrillation threshold in the perfused rat heart

  1991cited by this paper
• Regulation of K+ channels in cardiac myocytes by free fatty acids.

  1990cited by this paper
• Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

  1989cited by this paper
• Identification of NaK-ATPase inhibitors in human plasma as nonesterified fatty acids and lysophospholipids.

  1986cited by this paper
• Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats.

  1985cited by this paper
• Characterization of digitalis-like factors in human plasma. Interactions with NaK-ATPase and cross-reactivity with cardiac glycoside-specific antibodies.

  1985cited by this paper
• Adipose tissue and platelet fatty acids and coronary heart disease in Scottish men.

  1984cited by this paper
• Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction.

  1983cited by this paper
• Effect of myocardial ischaemia and antilipolytic agents on lipolysis and fatty acid metabolism in the in situ dog heart.

  1979cited by this paper
• Metabolic response of the heart in acute myocardial infarction in man.

  1978cited by this paper
• Relationship of epicardial ST segment elevation to the plasma free fatty acid/albumin ratio during coronary occlusion in dogs.

  1976cited by this paper
• Turnover of plasma glucose and free fatty acids in patients on the first day after myocardial infarction.

  1976cited by this paper
• Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic-acid analogue.

  1975cited by this paper
• Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size.

  1975cited by this paper
• Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle.

  1974cited by this paper
• Initial metabolic and hormonal response to acute myocardial infarction.

  1974cited by this paper
• Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion.

  1973cited by this paper
• The effect of a high molar FFA-albumin ratio in the perfusion medium on rhythm and contractility of the isolated rat heart.

  1973cited by this paper
• Control of insulin secretion by catecholamines, stress, and the sympathetic nervous system.

  1973cited by this paper
• Metabolic Response during Impending Myocardial Infarction: I. Relevance of Studies of Glucose and Fatty Acid Metabolism in Animals

  1972cited by this paper
• Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs.

  1971cited by this paper
• A metabolic cause for arrhythmias during acute myocardial hypoxia.

  1970cited by this paper
• Arrhythmias following infusions of fatty acids.

  1970cited by this paper
• Free fatty acids, heparin, and arrhythmias during experimental myocardial infarction.

  1969cited by this paper
• THE TRANSPORT AND UTILIZATION OF FREE FATTY ACID

  1968cited by this paper
• Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction.

  1968cited by this paper
• THE MECHANISM OF THE LIPOLYTIC ACTION OF CATECHOLAMINES

  1967cited by this paper
• Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction.

  1967cited by this paper
• Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion.

  1966cited by this paper

• Association between Free Fatty Acid and 3-Month Prognosis of acute ischemic stroke.

  2026cites this paper
• Elevated Free Fatty Acid Levels Predict Recurrence After Catheter Ablation in Patients With Atrial Fibrillation: Initial Experience From a Single Center

  2025cites this paper
• Plasma-Supplemented Red Cell Concentrates as Alternatives to Whole Blood in Porcine Ex Vivo Heart Perfusion.

  2025cites this paper
• The relationship of glycosylated hemoglobin A1c and Apolipoprotein A‑1 ratio on short-term prognosis in STEMI patients following PCI: a retrospective study

  2025cites this paper
• The abnormalities of free fatty acid metabolism in patients with hypertrophic cardiomyopathy, a single-center retrospective observational study

  2024cites this paper
• Increased circulating uric acid aggravates heart failure via impaired fatty acid metabolism

  2023cites this paper
• Elevated shock index and modified shock index are associated with mortality and major adverse cardiac events in patients with acute myocardial infarction: A systematic review and meta-analysis

  2022cites this paper
• The effect of stress hyperglycemıa seen ın acute ST-segment elevatıon ın myocardıal ınfarctıon on ın-hospıtal mortalıty.

  2022cites this paper
• Potentials of Soil on Palm Kernel Oil Free Fatty Acid

  2022cites this paper
• Admission hyperglycemia in acute myocardial infarction is associated with an increased risk of arrhythmias: A systematic review and meta‐analysis

  2022cites this paper
• Biochanin A attenuates obesity cardiomyopathy in rats by inhibiting oxidative stress and inflammation through the Nrf-2 pathway

  2021cites this paper
• Long Term Outcome Prediction in Stemi/Nstemi Patients By Means of the Model Consisting of Simple Clinical Parameters

  2021cites this paper
• Survival and Physiological Recovery after Capture by Hookline: The Case Study of the Blackspot Seabream (Pagellus bogaraveo)

  2021cites this paper
• Impact of prediabetes on cardiovascular disease risk in patients with acute myocardial infarctions

  2021cites this paper
• Association of Serum Nonesterified Fatty Acids with Cardiovascular Event in Patients with Chronic Kidney Disease

  2021cites this paper
• The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein A-l ratio in predicting cardiovascular outcomes in acute coronary syndrome.

  2020cites this paper
• Vitamin D3 intake as modulator for the early biomarkers of myocardial tissue injury in diabetic hyperlipidaemic rats

  2020influential citation
• GENDER-RELATED ALTERATIONS IN FREE FATTY ACIDS AND OXIDATIVE STRESS IN HYPERTENSION CO-MORBIDLY OCCURRING WITH TYPE 2 DIABETES MELLITUS

  2019cites this paper
• Akt is a critical node of acute myocardial insulin resistance and cardiac dysfunction after cardiopulmonary bypass.

  2019cites this paper
• Nonesterified fatty acids, cognitive decline, and dementia.

  2019cites this paper
• Epicardial Adipose Tissue Thickness as an Independent Predictor of Ventricular Tachycardia Recurrence Following Ablation.

  2019cites this paper
• Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation

  2018cites this paper
• Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model

  2018cites this paper
• Abbreviations AMI : acute myocardial infarction AVB : atrioventricular block BBB : bundle branch block DM : diabetes mellitus MVT : malignant ventricular tachyarrhythmias STEMI : ST elevation myocardial infarction

  2018cites this paper
• Sex-Dimorphic Association of Plasma Fatty Acids with Cardiovascular Fitness in Young and Middle-Aged General Adults: Subsamples from NHANES 2003–2004

  2018cites this paper
• In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome

  2016cites this paper
• Role of adipose tissue in the pathogenesis of cardiac arrhythmias.

  2016cites this paper
• DIAGNOSIS OF MYOCARDIAL ISCHEMIA USING PLASMA FREE FATTY ACID AS A BIOMARKER

  2015cites this paper
• Effects of Glucose Load on Catabolism during Propofol-Based Anesthesia with Remifentanil in Patients with Diabetes Mellitus: A Prospective Randomized Trial

  2015cites this paper
• The Effects of Glucose Load on Catabolism during Remifentanil-Based Anesthesia in Patients with Diabetes Mellitus: A Prospective Randomized Trial

  2015cites this paper
• Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.

  2015cites this paper
• High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients

  2014cites this paper
• Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome.

  2014cites this paper
• L-carnitine for the treatment of acute myocardial infarction.

  2014cites this paper
• Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction

  2014cites this paper
• Usefulness of Serum Unbound Free Fatty Acid Levels to Predict Death Early in Patients with ST Segment Elevation Myocardial Infarction[From the TIMI II Trial]

  2014cites this paper
• Elevated plasma free fatty acids are associated with sudden death: a prospective community-based evaluation at the time of cardiac arrest.

  2014cites this paper
• Astragali Radix protects myocardium from ischemia injury by modulating energy metabolism.

  2014cites this paper
• РОЛЬ ДИСЛИПИДЕМИЙ В МОДИФИКАЦИЯХ ЭНЕРГЕТИЧЕСКИХ И ПЛАСТИЧЕСКИХ ПРОЦЕССОВ В КАРДИОМИОЦИТАХ

  2014cites this paper
• Usefulness of serum unbound free fatty acid levels to predict death early in patients with ST-segment elevation myocardial infarction (from the Thrombolysis In Myocardial Infarction [TIMI] II trial).

  2014cites this paper
• Plasma Free Fatty Acids and Risk of Heart Failure: The Cardiovascular Health Study

  2013cites this paper
• Role of Free Fatty Acids in Physiological Conditions and Mitochondrial Dysfunction

  2013cites this paper
• Plasminogen activator inhibitor-1, free fatty acids, and insulin resistance in patients with myocardial infarction

  2013cites this paper
• Plasminogen activator inhibitor- , free fatty acids, and insulin resistance in patients with myocardial infarction

  2013cites this paper
• CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis.

  2012cites this paper
• Nonesterified Fatty Acids and Risk of Sudden Cardiac Death in Older Adults

  2012cites this paper
• Free fatty acids and acute coronary syndromes--the history.

  2011cites this paper
• Targeted and non-targeted metabolic time trajectory in plasma of patients after acute coronary syndrome.

  2011cites this paper
• Etude de la fréquence des déficits enzymatiques de la bêta-oxydation mitochondriale des acides gras chez les patients adultes ayant présenté des morts subites cardiaques inexpliquées

  2011cites this paper
• Prognostic implications of stress hyperglycemia in acute ST elevation myocardial infarction. Prospective observational study.

  2011influential citation
• Acute myocardial infarction: high risk ventricular tachyarrhythmias and admission glucose level in patients with and without diabetes mellitus.

  2011cites this paper
• Biochemical markers in acute coronary syndrome.

  2011cites this paper
• Prognostic Implications of Stress Hyperglycemia in Acute ST Elevation Myocardial Infarction. Prospective Observational Study

  2011cites this paper
• Elevated Free Fatty Acid is Associated with Cardioembolic Stroke Subtype

  2011cites this paper
• The Roles of Buyang Huanwu Decoction in Anti-Inflammation, Antioxidation and Regulation of Lipid Metabolism in Rats with Myocardial Ischemia

  2011cites this paper
• Lipid Emulsion as Antidote: An Exposition of Experimental Animal Models

  2010cites this paper
• ROLE OF SOME METABOLIC DISTURBANCES IN DEVELOPMENT OF CARDIAC ARRHYTHMIAS IN PATIENTS WITH ACUTE POISONING WITH ACETIC ACID

  2010cites this paper
• Control of free fatty acids during acute myocardial ischaemia

  2010cites this paper
• Role of arachidonic acid, lipoxygenase, and mitochondrial depolarization in reperfusion arrhythmias.

  2010cites this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cites this paper
• Роль неэтерифицированных жирных кислот в патогенезе сердечно-сосудистых заболеваний

  2010cites this paper
• ROLE OF ARTERIAL HYPERTENSION IN CARDIAC ABNORMALITIES IN PATIENTS WITH THYROTOXICOSIS

  2010cites this paper
• Adult presentations of medium-chain acyl-CoA dehydrogenase deficiency (MCADD)

  2009influential citation
• Long-term lifestyle and dietary habits in relation to cardiovascular mortality and life expectancy: a prospective cohort study

  2009cites this paper
• Intralipid Infusion Diminishes Return of Spontaneous Circulation After Hypoxic Cardiac Arrest in Rabbits

  2009cites this paper
• Effects of low and high carbohydrate meals on postprandial concentrations of circulating plasma lipids.

  2009cites this paper
• Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

  2008cites this paper
• Free fatty acids as a cardiovascular risk factor

  2008cites this paper
• Free fatty acids, cardiovascular mortality, and cardiometabolic stress.

  2007cites this paper
• Freie Fettsäuren als kardiovaskulärer Risikofaktor / Free fatty acids as a cardiovascular risk factor

  2007cites this paper
• Clinical Research Prevention and Epidemiology

  year unknowncites this paper
• Vascular Health and Risk Management Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Omega-3 Polyunsaturated Fatty Acids: a Necessity for a Comprehensive Secondary Prevention Strategy

  year unknowncites this paper